Loading…
Astrana Health, Inc. is projected to rise to $50.74 by 2027, a +32% move from its current price of $38.52. ASTH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $37.69 | $38.54 | $39.41 | +0.06% |
| May 30 | $37.37 | $38.56 | $39.80 | +0.11% |
| May 31 | $37.13 | $38.59 | $40.10 | +0.17% |
| Jun 1 | $36.93 | $38.61 | $40.37 | +0.23% |
| Jun 2 | $36.76 | $38.63 | $40.60 | +0.29% |
| Jun 3 | $36.60 | $38.65 | $40.82 | +0.34% |
| Jun 4 | $36.46 | $38.67 | $41.02 | +0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.46 | $38.67 | $41.02 | +0.40% |
| Week 2 | $35.73 | $38.83 | $42.20 | +0.80% |
| Week 3 | $35.21 | $38.99 | $43.17 | +1.21% |
| Week 4 | $34.79 | $39.14 | $44.03 | +1.61% |
| Week 5 | $34.45 | $39.30 | $44.83 | +2.02% |
| Week 6 | $34.16 | $39.46 | $45.58 | +2.43% |
| Week 7 | $33.90 | $39.61 | $46.29 | +2.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc.
and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Astrana Health, Inc. is currently trading at $37.85 and has a market capitalization of $1.88B, with a rank of 2049 by market cap. The stock sits in a near-term technical context that is currently favorable, and the longer horizon outlook suggests a path of growth through the late 2020s and into the 2030s and beyond.
A major floor 52.9% below — a decisive break under it would weaken the trend.
The nearest floor, 24.1% below — buyers have tended to step in here.
The nearest ceiling, 3.2% above — a clean break opens room to run.
A major ceiling 20.4% above — clearing it would confirm fresh momentum.
Key ASTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ASTH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.21 | Buy | $38.38 | Buy |
| MA 10 | $38.65 | Sell | $38.20 | Buy |
| MA 20 | $37.42 | Buy | $37.00 | Buy |
| MA 50 | $31.70 | Buy | $33.05 | Buy |
| MA 100 | $27.62 | Buy | $29.95 | Buy |
| MA 200 | $27.64 | Buy | $28.87 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.76 | Neutral |
| Stoch RSI (14) | 15.92 | Buy |
| CCI (20) | 44.82 | Neutral |
| Williams %R (14) | -33.70 | Info |
| MACD (12,26,9) | -0.37 | Sell |
| ROC (12) | -1.98 | Sell |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 66.30 | Neutral |
| TRIX (15) | 1.03 | Buy |
| Awesome (5,34) | 3.31 | Buy |
| Ultimate (7,14,28) | 58.15 | Neutral |
| Momentum (10) | -0.49 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 37.95 | Buy |
| ADX (14) | 41.35 | Buy |
| ATR (14) | 0.72 | Info |
The 30-day technical picture shows a bullish tilt, with the RSI at 60 and the 50-day simple moving average at $31.13 versus the 200-day simple moving average at $27.50, indicating a positive momentum backdrop. Near-term support is seen at $28.88 and resistance at $39.76, with the 30-day price range trading between $32.44 and $44.16.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.16 | $38.52 | $56.02 | 0% | Neutral | |
| $40.96 | $50.74 | $66.13 | +32% | Bullish | |
| $46.68 | $59.09 | $79.34 | +53% | Bullish | |
| $52.43 | $67.57 | $92.92 | +75% | Bullish | |
| $60.66 | $79.43 | $111.45 | +106% | Bullish | |
| $74.38 | $98.82 | $141.14 | +157% | Bullish | |
| $85.05 | $114.53 | $166.22 | +197% | Bullish | |
| $97.61 | $133.11 | $196.02 | +246% | Bullish | |
| $103.35 | $142.65 | $212.90 | +270% | Bullish | |
| $104.11 | $145.34 | $219.66 | +277% | Bullish | |
| $177.36 | $260.66 | $415.30 | +577% | Bullish | |
| $330.95 | $530.43 | $913.64 | +12.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $18.16 | $38.52 | $45.33 | +0.00% |
| June 2026 | $34.30 | $40.12 | $47.93 | +4.16% |
| July 2026 | $34.46 | $40.58 | $49.01 | +1.14% |
| August 2026 | $34.79 | $41.19 | $50.18 | +1.51% |
| September 2026 | $36.24 | $43.09 | $52.86 | +4.61% |
| October 2026 | $37.20 | $44.42 | $54.83 | +3.09% |
| November 2026 | $36.98 | $44.31 | $55.00 | -0.25% |
| December 2026 | $37.34 | $44.90 | $56.02 | +1.33% |
Click any year to see its month-by-month ASTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ASTH to range from $18.16 to $56.02 through 2026. The $38.52 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ASTH price prediction for 2027 points to an average of $50.74 (low $40.96, high $66.13) — a potential gain of +32% on today's $38.52. Momentum favours further upside here.
In 2028, ASTH is projected to trade between $46.68 and $79.34, averaging $59.09 — a potential gain of +53% from today's $38.52. That is up +16% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Astrana Health, Inc.'s 2029 outlook centres on $67.57, within a $52.43 to $92.92 range. That is up +14% on the projected 2028 average. That marks a +75% change versus current levels. Momentum favours further upside here.
By 2030, ASTH could reach as high as $111.45, with a base case around $79.43 and support toward $60.66 — roughly +106% from $38.52. Buyers look set to stay in control over this stretch.
Expect ASTH to range from $74.38 to $141.14 through 2031. The $98.82 average target implies a +157% move from current prices. That is up +24% on the projected 2030 average. Momentum favours further upside here.
The ASTH price prediction for 2032 points to an average of $114.53 (low $85.05, high $166.22) — a potential gain of +197% on today's $38.52. Buyers look set to stay in control over this stretch.
In 2033, ASTH is projected to trade between $97.61 and $196.02, averaging $133.11 — a potential gain of +246% from today's $38.52. That is up +16% on the projected 2032 average. Momentum favours further upside here.
Astrana Health, Inc.'s 2034 outlook centres on $142.65, within a $103.35 to $212.90 range. That is up +7% on the projected 2033 average. That marks a +270% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ASTH could reach as high as $219.66, with a base case around $145.34 and support toward $104.11 — roughly +277% from $38.52. Momentum favours further upside here.
Expect ASTH to range from $177.36 to $415.30 through 2040. The $260.66 average target implies a +577% move from current prices. That is up +79% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ASTH price prediction for 2050 points to an average of $530.43 (low $330.95, high $913.64) — a potential gain of +12.8x on today's $38.52. Momentum favours further upside here.
Investing $1,000 in ASTH today (≈ 25.96054 ASTH) could be worth
$13,770.34
+$12,770.34 (+1277%) by 2050 · US Dollar
Based on the average projected ASTH price of $530.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ASTHwould be worth at today's price.
$1,000 invested in ASTH on May 27, 2025 (≈ 40.048059 ASTH) would be worth
$1,542.65
+$542.65 (+54.3%) today · 1.54× · US Dollar
Based on a ASTH entry price of $24.97 vs. today's $38.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $38.76 | $993.81 | -0.6% |
| 1 month ago | $34.01 | $1,132.61 | +13.3% |
| 3 months ago | $20.91 | $1,842.18 | +84.2% |
| 6 months ago | $23.04 | $1,671.87 | +67.2% |
| 1 year ago | $24.97 | $1,542.65 | +54.3% |
| All time (5.0y) ago | $35.17 | $1,095.25 | +9.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ASTH forecast.
Our base-case forecast reaches $77.00 around 2030.
Implied market cap at $77.00: $3.82B
The multi-year forecast paints a bullish trajectory across the years beyond 2026. The 2026 forecast lists an average price of $37.85 with a min of $18.16 and a max of $55.58 and a neutral sentiment. The subsequent years show growing optimism and higher price targets: 2027 avg $49.61 (ROI 31.1%, bullish), 2028 avg $57.36 (ROI 51.5%, bullish), 2029 avg $65.90 (ROI 74.1%, bullish), 2030 avg $76.64 (ROI 102.5%, bullish), 2031 avg $95.36 (ROI 151.9%, bullish), 2032 avg $111.52 (ROI 194.6%, bullish), 2033 avg $128.53 (ROI 239.6%, bullish), 2034 avg $136.74 (ROI 261.3%, bullish), 2035 avg $139.60 (ROI 268.8%, bullish).
The longer-run forecasts project substantial upside: 2040 avg $248.86 (ROI 557.5%, bullish) and 2050 avg $504.52 (ROI 1233%, bullish). These figures illustrate a path of increasing value, with higher highs and strong long-term upside, but they are estimates and carry uncertainty.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $76.64, a minimum of $58.09, and a maximum of $108.52, with an expected ROI of 102.5% and bullish sentiment.
The forecast from 2027 onward shows bullish sentiment with rising average prices: 2027 avg $49.61 (ROI 31.1%), 2028 avg $57.36 (ROI 51.5%), and 2029 avg $65.90 (ROI 74.1%), continuing to 2030 avg $76.64 (ROI 102.5%). These are estimates and not guarantees.
Yes. The 2030 maximum is forecast at $108.52, indicating the possibility of exceeding $100 within the horizon, though this is not guaranteed.
The near-term setup shows bullish momentum with a 30-day range of $32.44 to $44.16, a support level at $28.88, and a resistance at $39.76. RSI is 60, SMA50 is $31.13, and SMA200 is $27.50, all suggesting upside potential in the short run.
The stock price is $37.85 and the market capitalization is $1.88B.
Astrana Health, Inc. Community Discussion
0Share your Astrana Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.